- Home
- TYRA vs MYN Comparison
TYRA vs MYN Comparison
Compare TYRA & MYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TYRA
- MYN
- Stock Information
- Founded
- TYRA 2018
- MYN 1992
- Country
- TYRA United States
- MYN United States
- Employees
- TYRA N/A
- MYN N/A
- Industry
- TYRA Biotechnology: Pharmaceutical Preparations
- MYN Finance Companies
- Sector
- TYRA Health Care
- MYN Finance
- Exchange
- TYRA Nasdaq
- MYN Nasdaq
- Market Cap
- TYRA 422.6M
- MYN 382.4M
- IPO Year
- TYRA 2021
- MYN N/A
- Fundamental
- Price
- TYRA $8.92
- MYN $9.58
- Analyst Decision
- TYRA Strong Buy
- MYN
- Analyst Count
- TYRA 6
- MYN 0
- Target Price
- TYRA $30.50
- MYN N/A
- AVG Volume (30 Days)
- TYRA 353.6K
- MYN 86.0K
- Earning Date
- TYRA 05-08-2025
- MYN 01-01-0001
- Dividend Yield
- TYRA N/A
- MYN 4.12%
- EPS Growth
- TYRA N/A
- MYN N/A
- EPS
- TYRA N/A
- MYN N/A
- Revenue
- TYRA N/A
- MYN N/A
- Revenue This Year
- TYRA N/A
- MYN N/A
- Revenue Next Year
- TYRA N/A
- MYN N/A
- P/E Ratio
- TYRA N/A
- MYN N/A
- Revenue Growth
- TYRA N/A
- MYN N/A
- 52 Week Low
- TYRA $6.42
- MYN $8.47
- 52 Week High
- TYRA $29.60
- MYN $10.62
- Technical
- Relative Strength Index (RSI)
- TYRA 45.95
- MYN 41.37
- Support Level
- TYRA $8.23
- MYN $9.51
- Resistance Level
- TYRA $8.80
- MYN $9.73
- Average True Range (ATR)
- TYRA 0.70
- MYN 0.18
- MACD
- TYRA 0.19
- MYN -0.01
- Stochastic Oscillator
- TYRA 75.30
- MYN 42.53
About TYRA Tyra Biosciences Inc.
Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.
About MYN Blackrock MuniYield New York Quality Fund Inc.Common Stock
Blackrock Muniyield NY Quality FD, Inc is a closed-end management investment company. Its objective is to provide shareholders with a high level of current income exempt from federal income taxes. The Fund invests in long-term municipal obligations that are investment grade quality or are considered by the Fund's investment adviser to be of comparable quality, at the time of investment.